Strain identifier
BacDive ID: 14456
Type strain: 
Species: Staphylococcus aureus
Strain history: <- IMET <- H. Knöll <- Serol. Bakt. Abt. IG Farben, Höchst, SG 511
NCBI tax ID(s): 1280 (species)
version 8.1 (current version)
General
@ref: 2554
BacDive-ID: 14456
DSM-Number: 6247
keywords: Bacteria, aerobe, mesophilic, human pathogen
description: Staphylococcus aureus DSM 6247 is an aerobe, mesophilic human pathogen of the family Staphylococcaceae.
NCBI tax id
- NCBI tax id: 1280
- Matching level: species
strain history
- @ref: 2554
- history: <- IMET <- H. Knöll <- Serol. Bakt. Abt. IG Farben, Höchst, SG 511
doi: 10.13145/bacdive14456.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/bacillota
- domain: Bacteria
- phylum: Bacillota
- class: Bacilli
- order: Caryophanales
- family: Staphylococcaceae
- genus: Staphylococcus
- species: Staphylococcus aureus
- full scientific name: Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980)
synonyms
- @ref: 20215
- synonym: Staphylococcus aureus subsp. anaerobius
@ref: 2554
domain: Bacteria
phylum: Firmicutes
class: Bacilli
order: Bacillales
family: Staphylococcaceae
genus: Staphylococcus
species: Staphylococcus aureus
full scientific name: Staphylococcus aureus Rosenbach 1884
type strain: no
Culture and growth conditions
culture medium
- @ref: 2554
- name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)
- growth: yes
- link: https://mediadive.dsmz.de/medium/92
- composition: Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water
culture temp
| @ref | growth | type | temperature | range |
|---|---|---|---|---|
| 2554 | positive | growth | 37 | mesophilic |
| 59547 | positive | growth | 37 | mesophilic |
Physiology and metabolism
oxygen tolerance
- @ref: 59547
- oxygen tolerance: aerobe
metabolite utilization
| @ref | Chebi-ID | metabolite | utilization activity | kind of utilization tested |
|---|---|---|---|---|
| 68375 | 16199 | urea | + | hydrolysis |
| 68375 | 29016 | arginine | + | hydrolysis |
| 68375 | 18257 | ornithine | - | degradation |
| 68375 | 4853 | esculin | - | hydrolysis |
| 68375 | 17634 | D-glucose | + | fermentation |
| 68375 | 15824 | D-fructose | + | fermentation |
| 68375 | 16024 | D-mannose | + | fermentation |
| 68375 | 17306 | maltose | + | fermentation |
| 68375 | 17716 | lactose | + | fermentation |
| 68375 | 27082 | trehalose | + | fermentation |
| 68375 | 16899 | D-mannitol | + | fermentation |
| 68375 | 16634 | raffinose | - | fermentation |
| 68375 | 17057 | cellobiose | - | fermentation |
| 68375 | 17632 | nitrate | + | reduction |
| 68375 | 17992 | sucrose | + | fermentation |
| 68375 | 59640 | N-acetylglucosamine | + | fermentation |
| 68375 | 32528 | turanose | + | fermentation |
| 68375 | 22599 | arabinose | - | fermentation |
metabolite production
- @ref: 68375
- Chebi-ID: 15688
- metabolite: acetoin
- production: yes
metabolite tests
- @ref: 68375
- Chebi-ID: 15688
- metabolite: acetoin
- voges-proskauer-test: +
enzymes
| @ref | value | activity | ec |
|---|---|---|---|
| 68375 | beta-glucuronidase | - | 3.2.1.31 |
| 68375 | pyrrolidonyl arylamidase | - | 3.4.19.3 |
| 68375 | alkaline phosphatase | + | 3.1.3.1 |
| 68375 | L-arginine arylamidase | - | |
| 68375 | beta-galactosidase | - | 3.2.1.23 |
| 68375 | beta-glucosidase | - | 3.2.1.21 |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 |
| 68375 | arginine dihydrolase | + | 3.5.3.6 |
| 68375 | urease | + | 3.5.1.5 |
API ID32STA
| @ref | URE | ADH Arg | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | NIT | VP | beta GAL | ArgA | PAL | PyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59547 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | - | + | + | + | - | - |
| 2554 | + | + | - | - | + | + | + | + | + | + | + | - | + | - | + | + | - | - | + | - | + | + | + | + | - | - |
Safety information
risk assessment
- @ref: 2554
- pathogenicity human: yes
- pathogenicity animal: yes
- biosafety level: 2
- biosafety level comment: Risk group (German classification)
External links
@ref: 2554
culture collection no.: DSM 6247, CCM 2524, IMET 10760, CCUG 52423, CNCTC Mau 43/60, SG 511
straininfo link
- @ref: 83597
- straininfo: 48129
literature
| topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
|---|---|---|---|---|---|---|---|---|
| Pathogenicity | 12928 | Antimicrobial activity of tibezonium (TBZ). | Veronese M, Salvaterra M, Setnikar I | Chemotherapy | 10.1159/000221976 | 1977 | *Anti-Bacterial Agents, Bacillus subtilis/drug effects, Bacteria/*drug effects, Benzodiazepines/*pharmacology, Corynebacterium/drug effects, Drug Resistance, Microbial, Escherichia coli/drug effects, Humans, Hydrogen-Ion Concentration, Saliva/microbiology, Smoking, Staphylococcus/drug effects, Staphylococcus aureus/drug effects, Streptococcus/drug effects, Streptococcus pneumoniae/drug effects, Streptococcus pyogenes/drug effects | |
| Pathogenicity | 382656 | [The clinical value of unspecific humoral immune parameters. Attempt at an immunogram. II. Quantitative determination of CH50E, CB50E, C3, C4 and lysozyme and measurement of indirect phagocytosis rate in the serum of patients with chronic pyelonephritis]. | Stelzner A, Stein G, Kittlick M | Z Gesamte Inn Med | 1979 | Adult, Chronic Disease, Complement C3/analysis, Complement C4/analysis, Complement System Proteins/*analysis, Escherichia coli/immunology, Humans, Muramidase/*analysis, Phagocytosis, Pyelonephritis/*immunology, Staphylococcus aureus/immunology | ||
| Metabolism | 1592684 | RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins. | Markus A, Klesel N, Wollmann T, Isert D, Limbert M, Schrinner E, Seibert G, Bauernfeind A, Jungwirth R, Wilhelm R, et al. | J Antibiot (Tokyo) | 10.7164/antibiotics.45.521 | 1992 | Anti-Bacterial Agents/*pharmacology, *Bacterial Proteins, Binding, Competitive, Carrier Proteins/*metabolism, Cephalosporins/metabolism/*pharmacology, Drug Stability, Gram-Negative Bacteria/drug effects/enzymology, *Hexosyltransferases, Microbial Sensitivity Tests, Muramoylpentapeptide Carboxypeptidase/*metabolism, Penicillin-Binding Proteins, Penicillins/*metabolism, *Peptidyl Transferases, Plasmids, Prodrugs/*pharmacology, beta-Lactamases/*metabolism | Pathogenicity |
| Metabolism | 2276601 | A novel labeling procedure of anteiso-fatty acid-containing lipids in staphylococci for investigating the effect of penicillin on lipid release. | Rozgonyi F, Hahn H, Labischinski H, Giesbrecht P | FEMS Microbiol Lett | 10.1016/0378-1097(90)90024-k | 1990 | Fatty Acids/*metabolism, Isoleucine/*metabolism, *Lipid Metabolism, Lipids/analysis, Lipopolysaccharides/analysis, Penicillin G/*pharmacology, Staphylococcus aureus/analysis/drug effects/*metabolism, Teichoic Acids/analysis | Pathogenicity |
| Pathogenicity | 2526432 | [Escape of hydrogen peroxide and oxygen from the root canal]. | Glockmann E, Oehring H, Hoffmann B, Lange G, Weisser G, Wunderlich I | Zahn Mund Kieferheilkd Zentralbl | 1989 | Dental Pulp Cavity/*drug effects/metabolism, Drug Evaluation, Preclinical, Humans, Hydrogen Peroxide/analysis/pharmacokinetics/pharmacology/*therapeutic use, In Vitro Techniques, Microbial Sensitivity Tests, Oxygen/*analysis, *Root Canal Irrigants, Root Canal Therapy, Staphylococcus aureus/drug effects/isolation & purification, Tooth Root/drug effects/metabolism/microbiology | Metabolism | |
| Pathogenicity | 2774816 | [Microbiologic studies of the lung clearance of rats after aerogenous long term exposure to ammonia]. | Kastner P, Mehlhorn G | Arch Exp Veterinarmed | 1989 | Ammonia/*toxicity, Animals, Female, Lung/*drug effects/microbiology/physiology, Mucociliary Clearance/*drug effects, Rats, Rats, Inbred Strains, Staphylococcus aureus | ||
| 2774835 | [The disposition and clearance of inhaled bacteria (Staphylococcus aureus) in the lungs of piglets]. | Kastner P, Mehlhorn G | Arch Exp Veterinarmed | 1989 | Aerosols, Animals, Lung/*microbiology, Lung Diseases/microbiology/*veterinary, Staphylococcal Infections/microbiology/*veterinary, Staphylococcus aureus/*physiology, Swine, Swine Diseases/*microbiology | |||
| Pathogenicity | 3142844 | Synthesis and structure-activity relationships in the cefpirome series. I. 7-[2-(2-Aminothiazol-4-yl)-2-(Z)-oxyiminoacetamido]-3-[(su bstituted-1-pyridinio)methyl]ceph-3-em-4-carboxylate s. | Lattrell R, Blumbach J, Duerckheimer W, Fehlhaber HW, Fleischmann K, Kirrstetter R, Mencke B, Scheunemann KH, Schrinner E, Schwab W, et al. | J Antibiot (Tokyo) | 10.7164/antibiotics.41.1374 | 1988 | Animals, Cephalosporins/*chemical synthesis/pharmacokinetics/pharmacology, Chemical Phenomena, Chemistry, Dogs, Haplorhini, Humans, Klebsiella/drug effects/enzymology, Magnetic Resonance Spectroscopy, Mice, Pseudomonas aeruginosa/drug effects, Staphylococcus/drug effects, Structure-Activity Relationship, beta-Lactamases/biosynthesis | Enzymology |
| Enzymology | 3324459 | Bovine leukocyte phagocytosis and bacteria killing monitored by intracellular acridine orange fluorescence and extracellular fluorescence quenching. | Zanetti M, Schmitt M, Lazary S | Vet Immunol Immunopathol | 10.1016/0165-2427(87)90017-1 | 1987 | Acridine Orange, Animals, Bacteria/*immunology, Cattle/*immunology, Cell Adhesion, Escherichia coli/immunology, Kinetics, Male, Microscopy, Fluorescence, Monocytes/*immunology, Neutrophils/*immunology, Opsonin Proteins, *Phagocytosis, Staphylococcus aureus/immunology | |
| Pathogenicity | 6240934 | [Effect of carrageenan, galactose and 2,4-dinitrophenol on leukocyte phagocytosis of Staphylococcus aureus and E. coli]. | Stelzner A, Schleef H, Kunze M | Allerg Immunol (Leipz) | 1984 | 2,4-Dinitrophenol, Carrageenan/*pharmacology, Dinitrophenols/*pharmacology, Escherichia coli/drug effects/immunology, Galactose/*pharmacology, Humans, Neutrophils/*drug effects, Phagocytosis/*drug effects, Staphylococcus aureus/drug effects/immunology, Time Factors | ||
| Pathogenicity | 6385566 | [Effect of colchicine and indomethacin on leukocytic phagocytosis of Staphylococcus aureus and E. coli]. | Schleef H, Stelzner A, Kunze M | Zentralbl Bakteriol Mikrobiol Hyg A | 1984 | Cell Division/drug effects, Colchicine/*pharmacology, Escherichia coli/drug effects/growth & development/*immunology, Female, Humans, Indomethacin/*pharmacology, Male, Neutrophils/*drug effects/immunology, Phagocytosis/*drug effects, Staphylococcus aureus/drug effects/growth & development/*immunology | ||
| Enzymology | 6618690 | Microbiological investigations on cryopreserved human semen. | Glander HJ, Schonborn C, Rytter M | Int J Androl | 10.1111/j.1365-2605.1983.tb00550.x | 1983 | Anti-Bacterial Agents, Bacteria/isolation & purification, Fungi/isolation & purification, Humans, In Vitro Techniques, Male, Semen/*microbiology, *Semen Preservation | Phylogeny |
| Pathogenicity | 6741334 | [Studies on the mycotic and bacterial risk of contamination and the use of nipagin in the artificial insemination of cryosperm]. | Glander HG, Rytter M, Schonborn C | Zentralbl Gynakol | 1984 | Anti-Bacterial Agents/pharmacology, Freezing, Fungi/drug effects, Humans, *Insemination, Artificial, Male, Microbial Sensitivity Tests, Parabens/*pharmacology, Risk, *Semen Preservation, Spermatozoa/*microbiology, Staphylococcus aureus/drug effects, Streptococcus/drug effects | ||
| Pathogenicity | 7237865 | Measurements of nonspecific humoral immune parameters in patients with chronic pyelonephritis. | Stein G, Stelzner A | Clin Nephrol | 1981 | *Antibody Formation, Autoantibodies/immunology, Complement C3/immunology, Complement C4/immunology, Humans, Immunoglobulin A/immunology, Immunoglobulin D/immunology, Immunoglobulin G/immunology, Immunoglobulin M/immunology, Muramidase/immunology, Phagocytosis, Pyelonephritis/*immunology | ||
| Metabolism | 8585719 | Staphylococcus aureus penicillin-binding protein 4 and intrinsic beta-lactam resistance. | Henze UU, Berger-Bachi B | Antimicrob Agents Chemother | 10.1128/AAC.39.11.2415 | 1995 | ATP-Binding Cassette Transporters, Amino Acid Sequence, Anti-Bacterial Agents/metabolism/*pharmacology, Bacterial Outer Membrane Proteins/genetics/metabolism, *Bacterial Proteins, Base Sequence, Carrier Proteins/chemistry/genetics/*physiology, Cloning, Molecular, DNA, Bacterial/analysis, Genes, Bacterial, *Hexosyltransferases, Methicillin Resistance/*genetics, Molecular Sequence Data, Muramoylpentapeptide Carboxypeptidase/chemistry/genetics/*physiology, Mutation, Open Reading Frames, Penicillin-Binding Proteins, Penicillins/metabolism, *Peptidyl Transferases, Plasmids, Restriction Mapping, Staphylococcus aureus/chemistry/*drug effects/genetics/*metabolism, beta-Lactam Resistance/genetics, beta-Lactams | Enzymology |
| Enzymology | 10319161 | Antibacterial phenylpropanoid glycosides from Paulownia tomentosa Steud. | Kang KH, Jang SK, Kim BK, Park MK | Arch Pharm Res | 10.1007/BF02979128 | 1994 | Anti-Bacterial Agents/*isolation & purification/pharmacology, Bacteria/drug effects, Glucosides/*chemistry, Magnetic Resonance Spectroscopy, Microbial Sensitivity Tests, Plants, Medicinal/*chemistry | Phylogeny |
| Pathogenicity | 15848746 | Volsurf analysis of carbapenem antibiotics. | Doddareddy MR, Cha JH, Cho YS, Koh HY, Yoo KH, Kim DJ, Pae AN | Bioorg Med Chem | 10.1016/j.bmc.2005.03.018 | 2005 | Anti-Bacterial Agents/*chemistry/*pharmacology, Carbapenems/*chemistry/*pharmacology, Escherichia coli/*drug effects, Microbial Sensitivity Tests, Models, Molecular, Quantitative Structure-Activity Relationship, Staphylococcus aureus/*drug effects | |
| Pathogenicity | 18174202 | Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'. | Pag U, Oedenkoven M, Sass V, Shai Y, Shamova O, Antcheva N, Tossi A, Sahl HG | J Antimicrob Chemother | 10.1093/jac/dkm479 | 2008 | Amino Acid Sequence/genetics, Anti-Infective Agents/*chemistry/pharmacology, Humans, Microbial Sensitivity Tests/methods, Molecular Sequence Data, Peptides/*chemistry/*genetics/pharmacology, Protein Structure, Secondary/drug effects/physiology | Genetics |
| Pathogenicity | 18455476 | Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. | Sass V, Pag U, Tossi A, Bierbaum G, Sahl HG | Int J Med Microbiol | 10.1016/j.ijmm.2008.01.011 | 2008 | Anaerobiosis, Anti-Bacterial Agents/*pharmacology, Biological Transport, Active/drug effects, Cell Wall/metabolism, Colony Count, Microbial, Energy Metabolism/drug effects, Gene Deletion, Gene Expression Profiling, Genes, Bacterial, Humans, Membrane Transport Proteins/biosynthesis, Microbial Sensitivity Tests, Microbial Viability, Oligonucleotide Array Sequence Analysis, Protein Biosynthesis/drug effects, Staphylococcus aureus/*drug effects/genetics, beta-Defensins/*pharmacology | Metabolism |
| Pathogenicity | 18456858 | Insights into the mode of action of chitosan as an antibacterial compound. | Raafat D, von Bargen K, Haas A, Sahl HG | Appl Environ Microbiol | 10.1128/AEM.00453-08 | 2008 | Anti-Bacterial Agents/*pharmacology, Cell Membrane/drug effects, Cell Wall/drug effects, Chitosan/*pharmacology, Colony Count, Microbial, Gene Expression/drug effects, Gene Expression Profiling, Membrane Potentials/drug effects, Microbial Sensitivity Tests, Microbial Viability, Microscopy, Electron, Transmission, Permeability/drug effects, Potassium/metabolism, Staphylococcus/*drug effects/growth & development/ultrastructure | Metabolism |
| Genetics | 19138560 | Native graS mutation supports the susceptibility of Staphylococcus aureus strain SG511 to antimicrobial peptides. | Sass P, Bierbaum G | Int J Med Microbiol | 10.1016/j.ijmm.2008.10.005 | 2009 | Amino Acid Sequence, Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/biosynthesis/*genetics, Bacteriocins/*pharmacology, Codon, Nonsense, Gene Expression Profiling, Gene Expression Regulation, Bacterial, Genetic Complementation Test, Histidine Kinase, Membrane Transport Proteins/biosynthesis, Microbial Sensitivity Tests, Molecular Sequence Data, Mutagenesis, Insertional, *Point Mutation, Protein Kinases/*genetics/physiology, Sequence Analysis, DNA, Staphylococcus aureus/*drug effects/genetics | Transcriptome |
| Pathogenicity | 21103541 | Antimicrobial phenalenone derivatives from the marine-derived fungus Coniothyrium cereale. | Elsebai MF, Kehraus S, Lindequist U, Sasse F, Shaaban S, Gutschow M, Josten M, Sahl HG, Konig GM | Org Biomol Chem | 10.1039/c0ob00625d | 2010 | Anti-Bacterial Agents/*chemistry/pharmacology, Ascomycota/*chemistry, Enzyme Inhibitors/chemistry/pharmacology, Humans, Leukocytes/drug effects/enzymology, Microbial Viability/drug effects, Molecular Structure, Pancreatic Elastase/antagonists & inhibitors, Phenalenes/*chemistry/pharmacology | Enzymology |
| Metabolism | 23350642 | Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus. | Wencewicz TA, Long TE, Mollmann U, Miller MJ | Bioconjug Chem | 10.1021/bc300610f | 2013 | Anti-Bacterial Agents/*administration & dosage/chemistry/metabolism, Drug Delivery Systems/*methods, Ferrous Compounds/*administration & dosage/chemistry/metabolism, Fluoroquinolones/*administration & dosage/chemistry/metabolism, Hydroxamic Acids/*administration & dosage/chemistry/metabolism, Microbial Sensitivity Tests, Peptides/*administration & dosage/chemistry/metabolism, Siderophores/*administration & dosage/chemistry/metabolism, Staphylococcus aureus/*drug effects/metabolism | Pathogenicity |
| Pathogenicity | 27987856 | Development of in vitro resistance to chitosan is related to changes in cell envelope structure of Staphylococcus aureus. | Raafat D, Leib N, Wilmes M, Francois P, Schrenzel J, Sahl HG | Carbohydr Polym | 10.1016/j.carbpol.2016.09.075 | 2016 | Anti-Bacterial Agents/*chemistry, Chitosan/*chemistry, Microbial Sensitivity Tests, Staphylococcus aureus/*cytology/drug effects | |
| Metabolism | 28505405 | Structural Basis for Xenosiderophore Utilization by the Human Pathogen Staphylococcus aureus. | Endicott NP, Lee E, Wencewicz TA | ACS Infect Dis | 10.1021/acsinfecdis.7b00036 | 2017 | Binding, Competitive, Cations, Deferoxamine/analogs & derivatives/*metabolism/pharmacology, Gene Expression, Iron/*metabolism, Kinetics, Membrane Transport Proteins/genetics/*metabolism, Methicillin-Resistant Staphylococcus aureus/drug effects/genetics/*metabolism, Models, Molecular, Periplasmic Binding Proteins/genetics/*metabolism, Protein Binding, Siderophores/chemical synthesis/*metabolism/pharmacology, Static Electricity, Structure-Activity Relationship | Enzymology |
| Genetics | 29429584 | Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems. | Muller A, Grein F, Otto A, Gries K, Orlov D, Zarubaev V, Girard M, Sher X, Shamova O, Roemer T, Francois P, Becher D, Schneider T, Sahl HG | Int J Med Microbiol | 10.1016/j.ijmm.2017.12.002 | 2017 | Bacterial Proteins/*genetics, Cell Membrane/metabolism, Daptomycin/*pharmacology, Drug Resistance, Bacterial/genetics, *Gene Expression Regulation, Bacterial, Genotype, Histidine Kinase/genetics, Microbial Sensitivity Tests, *Mutation, Proteomics, Staphylococcal Infections/microbiology, Staphylococcus aureus/*drug effects/enzymology/*genetics/physiology | Metabolism |
| Metabolism | 34045548 | A plant endophyte Staphylococcus hominis strain MBL_AB63 produces a novel lantibiotic, homicorcin and a position one variant. | Aftab Uddin M, Akter S, Ferdous M, Haidar B, Amin A, Shofiul Islam Molla AHM, Khan H, Islam MR | Sci Rep | 10.1038/s41598-021-90613-9 | 2021 | Bacteriocins/*analysis, Endophytes/*chemistry/metabolism, Mass Spectrometry, Staphylococcus hominis/*chemistry/metabolism | |
| 34896903 | The hypersusceptible antibiotic screening strain Staphylococcus aureus SG511-Berlin harbors multiple mutations in regulatory genes. | Dietrich A, Steffens U, Sass P, Bierbaum G | Int J Med Microbiol | 10.1016/j.ijmm.2021.151545 | 2021 | Anti-Bacterial Agents/pharmacology, Berlin, Genes, Regulator, *Methicillin-Resistant Staphylococcus aureus, Mutation, *Staphylococcus aureus/genetics | ||
| Metabolism | 36173303 | Cervimycin-Resistant Staphylococcus aureus Strains Display Vancomycin-Intermediate Resistant Phenotypes. | Dietrich A, Steffens U, Gajdiss M, Boschert AL, Droge JK, Szekat C, Sass P, Malik IT, Bornikoel J, Reinke L, Macek B, Franz-Wachtel M, Nieselt K, Harbig T, Scherlach K, Brotz-Oesterhelt H, Hertweck C, Sahl HG, Bierbaum G | Microbiol Spectr | 10.1128/spectrum.02567-22 | 2022 | Humans, Vancomycin/pharmacology/metabolism, Staphylococcus aureus/metabolism, *Methicillin-Resistant Staphylococcus aureus/genetics, Endopeptidase Clp/genetics/metabolism, Vancomycin Resistance/genetics, Histidine Kinase/genetics/metabolism, Proteomics, Microbial Sensitivity Tests, Bacterial Proteins/genetics/metabolism, *Staphylococcal Infections/drug therapy/microbiology, Anti-Bacterial Agents/pharmacology/therapeutic use, Heat-Shock Proteins/genetics/metabolism, Phenotype, *Polyketides/metabolism, Amino Acids/metabolism, *Biological Products | Phenotype |
Reference
| @id | authors | catalogue | doi/url | title |
|---|---|---|---|---|
| 2554 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 6247) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-6247 | |
| 20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |
| 59547 | Curators of the CCUG | Culture Collection University of Gothenburg (CCUG) (CCUG 52423) | https://www.ccug.se/strain?id=52423 | |
| 68375 | Automatically annotated from API ID32STA | |||
| 83597 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID48129.1 | StrainInfo: A central database for resolving microbial strain identifiers |